Abstract Coronavirus disease 2019 (COVID-19) vaccines have yielded definitive prevention
and major reductions in morbidity and mortality from severe acute respiratory syndrome …

Background Vaccinations have reduced severe burden of COVID-19 and allowed for lifting
of non-pharmaceutical interventions. However, with immunity waning alongside emergence …

Knowing vaccine effectiveness (VE) against variants of concern (VOCs) in the real-world
setting is essential for public health decision-making. A systematic landscape of the VE …

Where 2020 saw the development and testing of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has …

Abstract The coronavirus disease 2019 (COVID‐19) pandemic has entered its endemic
phase and we observe significantly declining infection fatality rates due to severe acute …

Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …

The entire world has been suffering from the coronavirus disease 2019 (COVID‐19)
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …

We performed a review study according to recent COVID-19 vaccines' real-world data to
provide comparisons between COVID-19 vaccines regarding their relative efficacy. Although …

Billions of doses of COVID-19 vaccines have been administered globally, dramatically
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …

About one year after the identification of the first cases of pneumonia due to a novel
coronavirus in Wuhan, several vaccines against SARS-CoV-2/COVID-19 started to be …